β-adrenergic receptor signaling mediated by β-arrestins and its potential role in heart failure
Authors:
- 18 November 2023
- journal article
- research article
- Published by Elsevier in Current Opinion in Physiology
- Vol. 37
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (23TPA1062201, R01-HL160029)
- American Heart Association
This publication has 68 references indexed in Scilit:
- Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptideNature, 2013
- β-arrestin-mediated receptor trafficking and signal transductionTrends in Pharmacological Sciences, 2011
- β-Arrestin Mediates β1-Adrenergic Receptor-Epidermal Growth Factor Receptor Interaction and Downstream SignalingJournal of Biological Chemistry, 2009
- β-Arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2Proceedings of the National Academy of Sciences, 2009
- β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivationProceedings of the National Academy of Sciences, 2008
- Nedd4 Mediates Agonist-dependent Ubiquitination, Lysosomal Targeting, and Degradation of the β2-Adrenergic ReceptorJournal of Biological Chemistry, 2008
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences, 2007
- Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK ActivationJournal of Biological Chemistry, 2007
- β-Arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expressionMolecular Immunology, 2007
- Mdm2 is involved in the ubiquitination and degradation of G‐protein‐coupled receptor kinase 2The EMBO Journal, 2006